Your session is about to expire
← Back to Search
CBT + Amitriptyline for Childhood Migraine
Study Summary
This trial will compare Cognitive Behavioral Therapy (CBT) via telehealth with a pill-based preventive therapy (amitriptyline) for treating childhood migraine. Results will help provide evidence-based, accessible care.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently being treated with amitriptyline or undergoing cognitive behavioral therapy for headaches.I am currently taking medication to prevent migraines.I am approved to take amitriptyline for preventing migraines.I have not had suicidal thoughts, attempts, bipolar disorder, heart rhythm issues, or severe constipation.I've had 4 or more headache days in the last 28 days.I am currently using Botox or CGRP antibodies for migraine prevention.I have been diagnosed with migraines, following international headache guidelines.I am a young person and I am pregnant.
- Group 1: CBT while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline)
- Group 2: CBT alone
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the eligibility criterion for this experiment encompass participants under 20 years of age?
"Patient inclusion criteria state that those between the ages of 10 to 17 are welcome to partake in this study."
Could I be a participant in this research study?
"The criterion for recruitment into this study necessitates that participants have a diagnosis of migraine and are between 10 to 17 years old. In total, 400 individuals must be accepted to join the research program."
How many venues are currently offering participation in this research?
"Currently, 14 different locations around the country are admitting patients into this trial; some of them being Phoenix, San Francisco and Aurora. To minimise travelling demands, it is suggested to pick a clinic in proximity."
Is there any capacity for new participants in this experiment?
"The information available on clinicaltrials.gov suggests that this study is not currently recruiting participants, as the trial was most recently updated in May of 2023. Nevertheless, there are 1250 other trials actively seeking patients at present."
Share this study with friends
Copy Link
Messenger